News

Mark Maddry Takes the Helm as Syniverse's CFO in Milestone Move

Mark Maddry Takes the Helm as Syniverse's CFO in Milestone Move

Mark Maddry Takes Over as CFO at Syniverse

Syniverse, recognized as the world's most connected company, recently made a significant leadership change by appointing Mark Maddry as its Chief Financial Officer. Maddry, who previously served as Senior Vice President of Business Performance, has a robust background in financial strategy within the telecommunications industry, boasting over 25 years of experience.

Transition and Leadership Insight

This appointment follows the previous tenure of Bill Sansalone, who joined Syniverse in early 2023 and has now stepped back into retirement. Andrew Davies, the CEO of Syniverse, highlighted Maddry's exceptional leadership qualities and deep understanding of the financial landscape during a transformative time for the company.

"Bill's guidance was key in fortifying our financial foundation and nurturing essential relationships with stakeholders," remarked Davies. He emphasized Maddry's invaluable contributions in supporting Sansalone, particularly in dealings with credit agencies and engaging investors.

Accomplishments in Financial Management

Mark Maddry's time at Syniverse has not gone unnoticed; he has significantly bolstered investor confidence. Noteworthy improvements under his watch include a remarkable 30% enhancement in financial visibility and an impressive 150% increase in ROI for initiatives aimed at growth.

Maddry conveyed optimism regarding Syniverse's future, stating, "We've built extraordinary momentum at Syniverse in recent years — and it's only the beginning. We have a notable chance to marry financial discipline with bold investments, driving growth while enhancing our leadership position in the market and creating lasting value for our stakeholders."

Background in Telecommunications

Prior to his successful tenure at Syniverse, Maddry honed his skills at Sprint/T-Mobile as Vice President of Financial Planning and Analysis. He played a crucial role in orchestrating the historic $26 billion merger between Sprint and T-Mobile. His contributions not only led to a remarkable 75% enhancement in shareholder value but also included spearheading financial integration efforts crucial for the company's long-term planning.

Maddry's expertise extended to managing a revenue budget of $30 billion, achieving significant savings through transformative initiatives, showcasing his capability to navigate complex financial landscapes.

Recognition and Future Initiatives

Mark's appointment follows Syniverse's recent accolade as a leader in mobile roaming, recognized for its continued efforts and advancements in connectivity transformation by Kaleido Intelligence. Such achievements position Syniverse at the forefront of the telecommunications industry, which is experiencing rapid changes and opportunities.

As the company continues to expand its influence within the sector, Maddry's leadership will be crucial in shaping and executing the financial strategies that will underpin future success. Syniverse aims to deliver smarter communication solutions, connecting people and devices seamlessly, thus optimizing the potential of digital interactions.

About Syniverse

Syniverse prides itself on being the world's most connected company, ensuring that networks, devices, and individuals can communicate effortlessly. It provides secure and global technology utilized by leading carriers and numerous top-tier companies globally.

For over three decades, Syniverse has been at the forefront of major advancements in communication technologies, driving innovations such as 5G and IoT. This ongoing commitment to intelligent connectivity reflects its dedication to enhancing how businesses and customers interact in today's digital landscape.

Frequently Asked Questions

Who is Mark Maddry?

Mark Maddry has been appointed as the Chief Financial Officer of Syniverse, bringing extensive experience in financial strategy from the telecommunications sector.

What role did Bill Sansalone play at Syniverse?

Bill Sansalone served as CFO at Syniverse before Maddry and contributed to strengthening the company's financial foundation.

What are Maddry's previous accomplishments?

Before joining Syniverse, Maddry played a key role in the Sprint and T-Mobile merger, leading to significant improvements in shareholder value and financial integration.

What recognition has Syniverse received recently?

Syniverse has been honored as a leader in mobile roaming for four consecutive years, highlighting its excellence and innovation in connectivity services.

What does Syniverse focus on?

The company focuses on connecting networks, devices, and people, enhancing communication technology, and driving intelligent connectivity solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading